The glitazones: proceed with caution

被引：35
作者：
Krische, D [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
WESTERN JOURNAL OF MEDICINE | 2000年 / 173卷 / 01期
关键词：
D O I：
10.1136/ewjm.173.1.54
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：54 / 57
页数：4
相关论文
共 56 条
[21]  
2-M
[22]   Effects of troglitazone - A new hypoglycemic agents in patients with NIDDM poorly controlled by diet therapy [J].
Iwamoto, Y ;
Kosaka, K ;
Kuzuya, T ;
Akanuma, Y ;
Shigeta, Y ;
Kaneko, T .
DIABETES CARE, 1996, 19 (02) :151-156
[23]   EFFECT OF NEW ORAL ANTIDIABETIC AGENT CS-045 ON GLUCOSE-TOLERANCE AND INSULIN-SECRETION IN PATIENTS WITH NIDDM [J].
IWAMOTO, Y ;
KUZUYA, T ;
MATSUDA, A ;
AWATA, T ;
KUMAKURA, S ;
INOOKA, G ;
SHIRAISHI, I .
DIABETES CARE, 1991, 14 (11) :1083-1086
[24]   Thiazolidinediones - The new insulin enhancers [J].
Jha, RJ .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1999, 21 (1-2) :157-166
[25]   Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes [J].
Kawai, T ;
Takei, I ;
Oguma, Y ;
Ohashi, N ;
Tokui, M ;
Oguchi, S ;
Katsukawa, F ;
Hirose, H ;
Shimada, A ;
Watanabe, K ;
Saruta, T .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (09) :1102-1107
[26]  
Kelly J, 2000, ARCH INTERN MED, V160, P871
[27]  
Kumar S, 1996, DIABETOLOGIA, V39, P701
[28]  
LEITER L, 1999, 59 ANN M AM DIAB ASS
[29]   Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus - A randomized, double-blind, placebo-controlled trial [J].
Maggs, DG ;
Buchanan, TA ;
Burant, CF ;
Cline, G ;
Gumbiner, B ;
Hsueh, WA ;
Inzucchi, S ;
Kelley, D ;
Nolan, J ;
Olefsky, JM ;
Polonsky, KS ;
Silver, D ;
Valiquett, TR ;
Shulman, GI .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (03) :176-185
[30]  
MATHISEN A, 1999, 59 ANN M AM DIAB ASS
123456